• DiscoveryProbe Natural Product Library Plus Workflow

  2026-09-28

  Build a target-to-cell screening workflow around a diverse, pre-dissolved natural product collection. The approach combines enzyme inhibition, parasite-cell validation, orthogonal controls, and high-content imaging to prioritize credible antiparasitic leads rather than isolated assay hits.

• FH1: Improving iPS Hepatocyte Workflows

  2026-09-28

  FH1 supports a maturity-first approach to iPS-derived hepatocyte cultures, with reported gains in albumin secretion, CYP3A4 levels, and hepatocyte-like morphology. This guide explains how to pilot the compound, qualify iHeps for liver research, and interpret its relevance—without confusing cell-maturation evidence with optogenetic gene-switch results.

• From Color to Causality: Nitrocefin in Resistance Research

  2026-09-27

  Nitrocefin turns β-lactamase activity into a visible signal. This article connects that practical readout to inhibitor discovery, including recent computational peptide-screening findings, and offers a strategy for translating enzyme measurements into stronger resistance research.

• YC-1: A Mechanistic Probe for Hypoxia and sGC

  2026-09-26

  YC-1 is a dual-action research compound whose HIF-1α and soluble guanylyl cyclase activities call for carefully separated assay readouts. This guide uses a recent trigeminal-neuralgia study to show how pathway-resolved experimental design can sharpen interpretation—without implying that YC-1 has been tested as a pain intervention.

• Milk Vesicles in Porcine Intestinal Stem Cell Models

  2026-09-25

  This study establishes porcine intestinal stem cell models with different epithelial regions and orientations to investigate milk-derived extracellular vesicle uptake. It reports apical uptake in selected models, inhibitor-sensitive internalization, and changes in colon-derived stemness- and differentiation-associated gene expression, offering a more physiologically relevant framework for intestinal vesicle research.

• DIDS Workflows for Cell Death and Ion Transport

  2026-09-25

  DIDS is a high-micromolar anion transport probe that can help separate chloride-current effects from cell-survival questions. This guide connects practical DIDS dose-finding and assay controls with research on post-near-death prometastatic states—while clarifying what the metastasis study does and does not show about the compound.

• Gepotidacin vs Nitrofurantoin in Uncomplicated UTI

  2026-09-24

  The EAGLE-2 and EAGLE-3 phase 3 trials found oral gepotidacin non-inferior to nitrofurantoin for uncomplicated urinary tract infection, with superiority shown in EAGLE-3. Their paired, double-blind design and combined symptom-and-culture endpoint provide useful evidence for evaluating a new oral antibiotic, while early stopping and population-specific eligibility constrain interpretation.

• Pentoxifylline in Assisted Male Reproduction

  2026-09-24

  This invited review evaluates in vitro Pentoxifylline use to stimulate sperm movement, particularly when selecting sperm for assisted reproduction. It finds encouraging effects on motility and related laboratory parameters, but emphasizes that evidence for ICSI clinical outcomes and safety remains limited.

• PP 1 in Cancer Research: A Pathway-Dissection Guide

  2026-09-23

  PP 1, a Src family tyrosine kinase inhibitor, can help test whether Src signaling contributes to cancer-cell phenotypes. This guide connects its pharmacology to a study of HER2-resistant breast cancer while clarifying what the evidence does—and does not—show.

• Tetrandrine: A Mechanism-to-Assay Research Guide

  2026-09-23

  Tetrandrine is a versatile Tetrandrine alkaloid for calcium signaling, ion channel modulation, inflammation, and cancer biology research. This guide connects its experimental handling and mechanistic value with lessons from structure-based natural-product screening.

• VX-702: Practical p38α MAPK Inhibition Workflows

  2026-09-22

  VX-702 combines selective p38α MAPK inhibition with practical applications in cytokine assays, platelet preservation, arthritis models, and ischemia-reperfusion research. This guide emphasizes concentration planning, pathway-specific controls, and troubleshooting that separates direct kinase inhibition from broader cellular stress effects.

• Nitrocefin for β-Lactamase Assays

  2026-09-22

  Nitrocefin converts β-lactamase hydrolysis into a clear yellow-to-red signal, enabling practical activity checks in purified enzymes, lysates, and resistance studies. This guide connects assay setup with GOB-38 research, inhibitor screening, comparative substrate profiling, and troubleshooting strategies.

• Hesperadin: Aurora B Kinase Inhibitor Workflow

  2026-09-21

  Hesperadin provides a practical way to connect Aurora B activity with histone H3 phosphorylation, chromosome behavior, cytokinesis, and DNA-content changes. This workflow combines dose-response design, orthogonal mitotic readouts, and checkpoint-aware interpretation for more reliable cell-cycle and cancer research.

• DIDS and Cell-State Assay Design

  2026-09-21

  DIDS is more than a chloride-channel probe: its use in near-death tumor-cell models reveals how pharmacologic rescue can shape mechanistic conclusions. This article connects DIDS transport biology, assay controls, and the PAME metastasis framework while defining practical limits for interpretation.

• Pam3CSK4 TLR1/2 Agonist Workflows

  2026-09-20

  Build reproducible innate-immunity assays with Pam3CSK4, from macrophage cytokine and nitric oxide measurements to allergic airway inflammation models. A defined TLR1/2 trigger also provides a practical comparator for testing whether neural stimulation changes downstream immune outputs.

551 records 3/37 page Previous Next 12345 下5页 Last page